# Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008

> **NCT05416021** · PHASE1 · COMPLETED · sponsor: **International Partnership for Microbicides, Inc.** · enrollment: 124 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** dapivirine

## Key facts

- **NCT ID:** NCT05416021
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-01
- **Primary completion:** 2024-04-02
- **Final completion:** 2024-07-02
- **Target enrollment:** 124 (ACTUAL)
- **Last updated:** 2024-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05416021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05416021, "Relative Bioavailability Trial of Dapivirine Ring-004 and Ring-008". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05416021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*